Regulatory cascades in gastrointestinal proliferation

胃肠道增殖的调节级联反应

基本信息

  • 批准号:
    9474868
  • 负责人:
  • 金额:
    $ 39.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-20 至 2022-07-31
  • 项目状态:
    已结题

项目摘要

The intestinal epithelium is one of the most rapidly renewing tissues in the body, and thus the ideal tissue to study somatic stem and progenitor cell biology. The small intestinal epithelium is composed of a single layer of cells that contains four major differentiated cell types as well as intestinal stem cells (ISCs) and progenitor or transit amplifying cells that replenish differentiated cells throughout life. While the past twenty years have seen great progress in our understanding of the signaling pathways and transcriptional regulators that control intestinal proliferation and differentiation, our understanding of the epigenetic factors that control these important processes is rather limited. Equally important is the identification of the intestinal stem cell niche, and the characterization of its function in molecular detail. To address this knowledge gap, I propose the following Specific Aims: In specific Aim 1, we will determine if Foxl1+ subepithelial telocytes are required for providing critical Wnt signals during gastrointestinal development and in R-spondin free enteroid culture. We will employ our newly developed genetic and molecular tools to determine the signaling pathways controlled by telocytes during intestinal development using mouse models. In Aim 2, we will investigate the contribution of polycomb complex mediated gene repression via histone H3K27 trimethylation on intestinal stem cell biology and regeneration. To this end, we will employ tissue and cell type specific gene ablation of two genes encoding critical H3K27me3 demethylases in the intestinal epithelium, both under homeostatic conditions and after ablation of Lgr5 stem cells. RELEVANCE (See instructions): Gastrointestinal cancer is a significant health problem, ranking fourth in incidence and second in death among cancers in the United States. Abnormal differentiation and increased proliferation of the intestinal epithelium are hallmarks of carcinogenesis. The molecular mechanisms that regulate cellular proliferation and differentiation in gastrointestinal development are far from being understood completely. Therefore, we will analyze the impact of the intestinal stem cell niche cells on intestinal growth and function, and test the contribution of histone demethylation to intestinal health.
肠上皮是体内更新最快的组织之一,因此是 研究体细胞干细胞和祖细胞生物学。小肠上皮由单层构成。 包含四种主要分化细胞类型的细胞以及肠道干细胞(ISCs)和祖细胞 或者运输放大细胞,在一生中补充分化的细胞。而在过去的二十年里 在我们对信号通路和转录调控因子的理解方面取得了很大进展 控制肠道增殖和分化,我们对控制表观遗传因素的理解 这些重要的进程相当有限。同样重要的是肠道干细胞的鉴定。 生态位,以及其功能的分子细节表征。为了解决这一知识鸿沟,我建议 以下是具体目标: 在特定的目标1中,我们将确定是否需要Foxl1+上皮下端粒细胞来提供关键的Wnt 在胃肠道发育和无R-响应素的肠样培养中的信号。我们将雇佣我们的员工 新开发的基因和分子工具来确定端细胞控制的信号通路 在肠道发育过程中使用小鼠模型。在目标2中,我们将调查以下方面的贡献 组蛋白H3K27三甲基化介导的多梳复合体对肠干细胞的基因抑制 生物学和再生。为此,我们将采用组织和细胞类型特异的基因消融两种 肠上皮中编码关键H3K27me3去甲基酶的基因,两者都处于动态平衡状态 Lgr5干细胞的培养条件和消融后。 相关性(请参阅说明): 胃肠道癌症是一个重大的健康问题,发病率排名第四,死亡率排名第二。 在美国的癌症中。肠道分化异常和增殖增加 上皮细胞是癌变的标志。调控细胞增殖的分子机制 而胃肠道发育过程中的分化还远未完全了解。因此,我们 将分析肠道干细胞巢细胞对肠道生长和功能的影响,并测试 组蛋白去甲基化对肠道健康的贡献。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KLAUS H KAESTNER其他文献

KLAUS H KAESTNER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KLAUS H KAESTNER', 18)}}的其他基金

The role of senescent beta cells in T1D and T2D
衰老 β 细胞在 T1D 和 T2D 中的作用
  • 批准号:
    10583684
  • 财政年份:
    2022
  • 资助金额:
    $ 39.64万
  • 项目类别:
The role of senescent beta cells in T1D and T2D
衰老 β 细胞在 T1D 和 T2D 中的作用
  • 批准号:
    10708994
  • 财政年份:
    2022
  • 资助金额:
    $ 39.64万
  • 项目类别:
Innovative Genetic Approaches to Enhance Liver Repopulation and Reduce Cancer Risk and Progression
增强肝脏再生并降低癌症风险和进展的创新遗传学方法
  • 批准号:
    10434813
  • 财政年份:
    2020
  • 资助金额:
    $ 39.64万
  • 项目类别:
Innovative Genetic Approaches to Enhance Liver Repopulation and Reduce Cancer Risk and Progression
增强肝脏再生并降低癌症风险和进展的创新遗传学方法
  • 批准号:
    10217062
  • 财政年份:
    2020
  • 资助金额:
    $ 39.64万
  • 项目类别:
Innovative Genetic Approaches to Enhance Liver Repopulation and Reduce Cancer Risk and Progression
增强肝脏再生并降低癌症风险和进展的创新遗传学方法
  • 批准号:
    10654627
  • 财政年份:
    2020
  • 资助金额:
    $ 39.64万
  • 项目类别:
The Human Pancreas Analysis Program for Type 2 Diabetes
2 型糖尿病人类胰腺分析项目
  • 批准号:
    10252957
  • 财政年份:
    2019
  • 资助金额:
    $ 39.64万
  • 项目类别:
The Human Pancreas Analysis Program for Type 2 Diabetes
2 型糖尿病人类胰腺分析项目
  • 批准号:
    10020973
  • 财政年份:
    2019
  • 资助金额:
    $ 39.64万
  • 项目类别:
The Human Pancreas Analysis Program for Type 2 Diabetes
2 型糖尿病人类胰腺分析项目
  • 批准号:
    10675236
  • 财政年份:
    2019
  • 资助金额:
    $ 39.64万
  • 项目类别:
The Human Pancreas Analysis Program for Type 2 Diabetes
2 型糖尿病人类胰腺分析项目
  • 批准号:
    10568985
  • 财政年份:
    2019
  • 资助金额:
    $ 39.64万
  • 项目类别:
The Human Pancreas Analysis Program for Type 2 Diabetes
2 型糖尿病人类胰腺分析项目
  • 批准号:
    10261669
  • 财政年份:
    2019
  • 资助金额:
    $ 39.64万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.64万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.64万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.64万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.64万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.64万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.64万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.64万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.64万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.64万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.64万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了